| Name | (1R)-1-[(3Z)-3-[5-(trifluoromethyl)benzimidazol-2-ylidene]-1,2-oxazol-5-yl]ethanamine |
|---|
| Molecular Formula | C13H11F3N4O |
|---|---|
| Molecular Weight | 296.24800 |
| Exact Mass | 296.08800 |
| PSA | 80.73000 |
| LogP | 3.95670 |
| HS Code | 2934999090 |
|---|
|
~47%
1095824-22-8 |
| Literature: Sunesis Pharmaceuticals, Inc. Patent: US2009/36419 A1, 2009 ; Location in patent: Page/Page column 88; 88-89 ; US 20090036419 A1 |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |